Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine

Advances in antigen targeting in veterinary medicine have gained traction over the years as an alternative approach for diseases that remain a challenge for traditional vaccines. In addition to the nature of the immunogen, antigen-targeting success relies heavily on the chosen receptor for its direc...

Full description

Bibliographic Details
Main Authors: Edgar Alonso Melgoza-González, Lorena Bustamante-Córdova, Jesús Hernández
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1080238/full
_version_ 1827931509910142976
author Edgar Alonso Melgoza-González
Lorena Bustamante-Córdova
Jesús Hernández
author_facet Edgar Alonso Melgoza-González
Lorena Bustamante-Córdova
Jesús Hernández
author_sort Edgar Alonso Melgoza-González
collection DOAJ
description Advances in antigen targeting in veterinary medicine have gained traction over the years as an alternative approach for diseases that remain a challenge for traditional vaccines. In addition to the nature of the immunogen, antigen-targeting success relies heavily on the chosen receptor for its direct influence on the elicited response that will ensue after antigen uptake. Different approaches using antibodies, natural or synthetic ligands, fused proteins, and DNA vaccines have been explored in various veterinary species, with pigs, cattle, sheep, and poultry as the most frequent models. Antigen-presenting cells can be targeted using a generic approach, such as broadly expressed receptors such as MHC-II, CD80/86, CD40, CD83, etc., or focused on specific cell populations such as dendritic cells or macrophages (Langerin, DC-SIGN, XCR1, DC peptides, sialoadhesin, mannose receptors, etc.) with contrasting results. Interestingly, DC peptides show high specificity to DCs, boosting activation, stimulating cellular and humoral responses, and a higher rate of clinical protection. Likewise, MHC-II targeting shows consistent results in enhancing both immune responses; an example of this strategy of targeting is the approved vaccine against the bovine viral diarrhea virus in South America. This significant milestone opens the door to continuing efforts toward antigen-targeting vaccines to benefit animal health. This review discusses the recent advances in antigen targeting to antigen-presenting cells in veterinary medicine, with a special interest in pigs, sheep, cattle, poultry, and dogs.
first_indexed 2024-03-13T06:53:46Z
format Article
id doaj.art-6ec40a03fbc54d03a04a18a9a4dc5bbc
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-13T06:53:46Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-6ec40a03fbc54d03a04a18a9a4dc5bbc2023-06-07T12:36:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-03-011410.3389/fimmu.2023.10802381080238Recent advances in antigen targeting to antigen-presenting cells in veterinary medicineEdgar Alonso Melgoza-GonzálezLorena Bustamante-CórdovaJesús HernándezAdvances in antigen targeting in veterinary medicine have gained traction over the years as an alternative approach for diseases that remain a challenge for traditional vaccines. In addition to the nature of the immunogen, antigen-targeting success relies heavily on the chosen receptor for its direct influence on the elicited response that will ensue after antigen uptake. Different approaches using antibodies, natural or synthetic ligands, fused proteins, and DNA vaccines have been explored in various veterinary species, with pigs, cattle, sheep, and poultry as the most frequent models. Antigen-presenting cells can be targeted using a generic approach, such as broadly expressed receptors such as MHC-II, CD80/86, CD40, CD83, etc., or focused on specific cell populations such as dendritic cells or macrophages (Langerin, DC-SIGN, XCR1, DC peptides, sialoadhesin, mannose receptors, etc.) with contrasting results. Interestingly, DC peptides show high specificity to DCs, boosting activation, stimulating cellular and humoral responses, and a higher rate of clinical protection. Likewise, MHC-II targeting shows consistent results in enhancing both immune responses; an example of this strategy of targeting is the approved vaccine against the bovine viral diarrhea virus in South America. This significant milestone opens the door to continuing efforts toward antigen-targeting vaccines to benefit animal health. This review discusses the recent advances in antigen targeting to antigen-presenting cells in veterinary medicine, with a special interest in pigs, sheep, cattle, poultry, and dogs.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1080238/fullantigen targetantigen presenting cellreceptorsveterinaryvaccines
spellingShingle Edgar Alonso Melgoza-González
Lorena Bustamante-Córdova
Jesús Hernández
Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine
Frontiers in Immunology
antigen target
antigen presenting cell
receptors
veterinary
vaccines
title Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine
title_full Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine
title_fullStr Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine
title_full_unstemmed Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine
title_short Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine
title_sort recent advances in antigen targeting to antigen presenting cells in veterinary medicine
topic antigen target
antigen presenting cell
receptors
veterinary
vaccines
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1080238/full
work_keys_str_mv AT edgaralonsomelgozagonzalez recentadvancesinantigentargetingtoantigenpresentingcellsinveterinarymedicine
AT lorenabustamantecordova recentadvancesinantigentargetingtoantigenpresentingcellsinveterinarymedicine
AT jesushernandez recentadvancesinantigentargetingtoantigenpresentingcellsinveterinarymedicine